KD Emrold Pharmaceuticals Private Limited

KD Emrold Pharmaceuticals Private Limited - chemicals in Delhi, India. Directors, charges & compliance details.
CIN U24299DL2021PTC391437 Incorporated 20 December 2021 ROC Delhi HQ Delhi, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2025
₹1.67 Lakh
▼ 48% YoY
Net loss · FY 2025
₹11,076
Net margin -6.6%
EBITDA · FY 2025
-₹7,725
EBITDA margin -4.6%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About KD Emrold Pharmaceuticals Private Limited

Data last updated:

KD Emrold Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 20 December 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2021PTC391437.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Veerendra Singh Dhakad and Anita.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kh No135 Ground Floor Bijapur Ext. Lal Dora Vill Budhpur Backside Cloud Farm, Delhi, India – 110036.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.67 Lakh, a decline of 48% compared to the previous year. For the same year it recorded a net loss of ₹11,076 (net margin -6.6%) and EBITDA of -₹7,725 (EBITDA margin -4.6%).

Company details

CIN U24299DL2021PTC391437
Registration Number 391437
Incorporation Date 20 December 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025

Contact details

KD Emrold Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.

  • Registered Address
    Kh No135 Ground Floor Bijapur Ext. Lal Dora Vill Budhpur Backside Cloud Farm, Delhi, India – 110036
  • Industry
    Chemicals, Other Chemical Product, Manufacturing, Fine Chemicals And Other Chemical Products
Comprehensive company report
KD Emrold Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of KD Emrold Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of KD Emrold Pharmaceuticals Private Limited, buy the company report.

Financials of KD Emrold Pharmaceuticals Private Limited

FY 2025 filings available

KD Emrold Pharmaceuticals Private Limited reported revenue of ₹1.67 Lakh (down 48% YoY) for FY 2025.

Revenue · FY 2025
₹1.67 Lakh ▼ 48%
Net loss · FY 2025
₹11,076 margin -6.6%
EBITDA · FY 2025
-₹7,725 margin -4.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 48%
EBITDA CAGR growth
1 year
▲ 73%
3 years · compounded
▲ 8%

Revenue fell 48% in the latest year. EBITDA rose 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹7,725
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹11,076
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin-4.6%
Net Profit Margin-6.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of KD Emrold Pharmaceuticals Private Limited, buy the company report.

Board of directors of KD Emrold Pharmaceuticals Private Limited

KD Emrold Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Veerendra Singh DhakadDirector20 Dec 20214 Years 10 MonthsCurrent
AnitaAdditional Director01 Aug 20251 Years 3 MonthsCurrent

Peer comparison

KD Emrold Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Raquel Pharmaceuticals Private Limited₹1.69 Lakh (FY 2020)-88.0%Vadodara, Gujarat, India
Lutika Pharmaceuticals Private Limited₹1.68 Lakh (FY 2025)9.0%Bharuch, Gujarat, India
KD Emrold Pharmaceuticals Private Limitedthis company₹1.67 Lakh (FY 2025)-₹11,076-6.6%-48.0%Delhi, India
Noracare Pharmaceuticals Private Limited₹1.66 Lakh (FY 2025)253.0%Ranchi, Jharkhand, India
Olive Pharmaceuticals Private Limited₹1.66 Lakh (FY 2017)23.0%New Delhi, Delhi, India

To see the full peer comparison of KD Emrold Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for KD Emrold Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for KD Emrold Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

KD Emrold Pharmaceuticals Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Anita was appointed as Additional Director on 01 Aug 2025.

AGM
Kd Emrold Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Anita was appointed as Additional Director.
Ceased
Rajendra Kumar Jain ceased to be Director.
Filing
Kd Emrold Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Rajendra Kumar Jain was appointed as Director.
Appointed
Veerendra Singh Dhakad was appointed as Director.
Incorporation
20 Dec 2021
Kd Emrold Pharmaceuticals Private Limited was registered on 20 Dec 2021 with Roc Delhi Ii & aged 4 years 10 months as per MCA records.

Frequently asked questions

KD Emrold Pharmaceuticals is an active private limited company based in Delhi, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 20 December 2021 (5+ years old) and is registered under CIN U24299DL2021PTC391437.

KD Emrold Pharmaceuticals has 2 current directors:

The latest financial statements of KD Emrold Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of KD Emrold Pharmaceuticals is U24299DL2021PTC391437. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

KD Emrold Pharmaceuticals was incorporated on 20 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of KD Emrold Pharmaceuticals by revenue are Raquel Pharmaceuticals Private Limited, Lutika Pharmaceuticals Private Limited, Noracare Pharmaceuticals Private Limited, Olive Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Anita was appointed as Additional Director on 01 Aug 2025. Rajendra Kumar Jain ceased to be Director on 01 Aug 2025. Rajendra Kumar Jain was appointed as Director on 20 Dec 2021. KD Emrold Pharmaceuticals has 4 board changes on record in total.

The registered office of KD Emrold Pharmaceuticals is at Kh No135 Ground Floor Bijapur Ext. Lal Dora Vill Budhpur Backside Cloud Farm, Delhi, India – 110036.

KD Emrold Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.

KD Emrold Pharmaceuticals can be reached at its registered office: Kh No135 Ground Floor Bijapur Ext. Lal Dora Vill Budhpur Backside Cloud Farm, Delhi, India – 110036.

KD Emrold Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.